Building The Noise with Monica Dudley - Weldon - EPISODE 013

Doctors told Monica Dudley-Weldon that her son might never walk or talk. One night, he unexpectedly said the words she had been waiting to hear: “I love you.”When Beckett was diagnosed with a SYNGAP1-related disorder, he was one of only six identified patients Monica could find. Getting that answer required 19 specialists, a $13,000 genetic test, a 14-week wait, and the willingness to take a chance when success was far from guaranteed.Monica refused to let the diagnosis become the end of Beckett’s story.A former science teacher, she founded the first organization dedicated to advancing SYNGAP1 research, awareness, and family support. Her work helped establish a patient registry, natural history research, an ICD-10 code, and new collaborations among families, researchers, biotechnology companies, and policymakers.That journey eventually led Monica into law, health policy, biotech strategy, and chemical and biological defense work with the federal government.IN THIS EPISODE, YOU’LL LEARN: Why Monica borrowed $13,000 for a genetic test with only a 20% chance of finding an answer  How Beckett became one of the earliest identified SYNGAP1 patients  How one family helped create an international rare disease movement  Why patient registries and natural history studies matter to drug development  How patient priorities can differ from what researchers expect  Why many rare disease nonprofits need more sustainable business models  How patient data can responsibly support future research  Why community conflict can drive away researchers and biotech companies  How families can recognize unsupported treatments and questionable medical claims  How rare disease advocacy prepared Monica for biotechnology and national defense  What personal loss, faith, and starting again taught her about leadership WHY THIS MATTERS:Rare disease families often live with immediate challenges including seizures, behavioral symptoms, intellectual disability, and uncertainty while treatments can take years or even decades to develop.Monica’s story demonstrates why patients and caregivers must have a meaningful voice in deciding what research addresses first. It also shows what can happen when lived experience is combined with science, business, law, policy, and persistent advocacy.A diagnosis can describe a condition, but it does not have to define a child’s future.CHAPTERS:00:00 Doctors Said He Would Never Talk 01:31 Meet Monica Dudley-Weldon 03:05 From Patient Advocacy to National Defense 08:39 Nineteen Specialists and a $13,000 Decision 10:17 A Genetic Test With a 20% Chance 11:35 Beckett Becomes Patient Number Six 12:42 Building a SYNGAP1 Research Movement 15:55 Turning a 30-Year Timeline Into Eight 22:07 Why Pharmaceutical Funding Is Complicated 24:29 A New Model for Rare Disease Research 28:11 Why Rare Disease Data Is So Valuable 31:30 Hearing What Beckett Would “Never” Do 34:00 The First Time Beckett Said “I Love You” 37:02 Building Something That Can Survive 39:37 When Politics Blocks Medical Innovation 43:22 Identifying Charlatans and Unsupported Treatments 46:56 A Classroom Experiment Inspires Real Research 50:13 What Patients Need Before a Cure 53:08 What Monica Would Tell Her Younger Self 55:50 Choosing Triumph Over TragedySubscribe to Building the Noise for more conversations about healthcare, biotechnology, patient advocacy, public policy, and the people working to improve broken systems.Listen to the full episode, share it with a parent, caregiver, researcher, or advocate who needs to hear it, and leave a rating or review to support the show.SYNGAP1, rare disease, rare disease advocacy, patient advocacy, genetic disorders, genetic testing, Monica Dudley-Weldon, SYNGAP1 research, patient-led research, special needs parenting, intellectual disability, epilepsy, biotechnology, healthcare policy, drug development, patient data, nonprofit leadership, medical research, national defense, Building the NoiseSupport the showBuilding the Noise with Matt Toresco